GB

Gundasamudrdha Basavarajappa Chandramohan

Active Director Director DIN 08610686
DIN 08610686 First appointment Nov 2019 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Nov 2019
Shareholding value •••• Premium profile

About Gundasamudrdha Basavarajappa Chandramohan

Data last updated:

Gundasamudrdha Basavarajappa Chandramohan is a Director at Amr Loans Private Limited (since 2025), Director at Amr Finance Private Limited (since 2025) and Director at Dhan Setu Fintech Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Financial Services, BFSI and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹21.5 Lakh; the largest is Amr Loans Private Limited at ₹20.2 Lakh (FY 2025). Earlier, Gundasamudrdha Basavarajappa Chandramohan was a Designated Partner at Kawaka Health Science Llp (2019–2020).

DIN 08610686
Primary Designation Director
Industry Financial Services
First Appointment 14 Nov 2019
Oldest Company Age 6 yrs
Largest company Amr Loans Private Limited · ₹20.2 Lakh (FY 2025)
Combined revenue ₹21.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amr Loans Private Limited U65999KA2020PTC131509
Director12 Jun 20252020₹20.2 Lakh (FY 2025)Active
Amr Finance Private Limited U65990KA2021PTC151810
Director12 Jun 20252021₹1.3 Lakh (FY 2025)Active
Dhan Setu Fintech Private Limited U66190KA2025PTC202355
Director05 May 20252025Active
Designated Partner08 Sep 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Nov 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Gundasamudrdha Basavarajappa Chandramohan

Directorship timeline

Open interactive timeline →
Nu-Prana Nourishment Llp
Amr Loans Private Limited
Dhan Setu Fintech Private Limited
Amr Finance Private Limited
Premium access

Shareholding and investment profile for Gundasamudrdha Basavarajappa Chandramohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gundasamudrdha Basavarajappa Chandramohan

Gundasamudrdha Basavarajappa Chandramohan currently holds 4 directorships: Amr Loans Private Limited (Director, since 12 Jun 2025, revenue ₹20.2 Lakh (FY 2025)); Amr Finance Private Limited (Director, since 12 Jun 2025, revenue ₹1.3 Lakh (FY 2025)); Dhan Setu Fintech Private Limited (Director, since 05 May 2025); Nu-Prana Nourishment Llp (Designated Partner, since 08 Sep 2020).

Gundasamudrdha Basavarajappa Chandramohan was first appointed on 14 Nov 2019 as Designated Partner at Kawaka Health Science Llp. The most recent appointment on record is 12 Jun 2025 at Amr Finance Private Limited.

The 2 current companies of Gundasamudrdha Basavarajappa Chandramohan that report revenue have a combined latest revenue of ₹21.5 Lakh: Amr Loans Private Limited ₹20.2 Lakh (FY 2025); Amr Finance Private Limited ₹1.3 Lakh (FY 2025).

Gundasamudrdha Basavarajappa Chandramohan held 1 earlier board appointment: Kawaka Health Science Llp (Designated Partner, 14 Nov 2019 to 29 May 2020).

The current boards of Gundasamudrdha Basavarajappa Chandramohan's companies include Kumar Ruthun (Amr Loans Private Limited), Jayaprasada Paramesh Naik (Amr Finance Private Limited), Chetan Krishnan (Dhan Setu Fintech Private Limited), Jayanthi Niranjan (Nu-Prana Nourishment Llp), Srinagesh Jayanthi (Nu-Prana Nourishment Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available